Lupin feels that there is a more sustainable higher margin opportunity in the complex products space, Gupta said. She, however, asserted that Lupin will not vacate the oral solids segment.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/dWjkSTP
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Lupin rationalising product portfolio in US to overcome price erosion impact: CEO
https://ift.tt/0zyfcYC
No comments:
Post a Comment